These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7850229)

  • 1. [Molecular bases of the fluorescence method in the determination of binding capacity of serum albumin].
    Miller IuI; Dobretsov GE
    Klin Lab Diagn; 1994; (5):20-3. PubMed ID: 7850229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fluorescent method of determination of serum albumin in hyperbilirubinemia].
    Miller IuI; Iushko EG; Dobretsov GE; Krasovitskiĭ BM; Aĭdyraliev RK
    Vopr Med Khim; 1990; 36(2):86-8. PubMed ID: 2363267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of oxidant-induced changes in albumin transport function with a fluorescent probe k-35. Effect of hypochlorite.
    Azizova OA; Aseychev AV; Beckman EM; Moskvina SN; Skotnikova OI; Smolina NV; Gryzunov YA; Dobretsov GE
    Bull Exp Biol Med; 2012 Apr; 152(6):712-6. PubMed ID: 22803171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent dye method for determination of the bilirubin-binding capacity of serum albumin.
    Lee K; Gartner LM; Zarafu I
    J Pediatr; 1975 Feb; 86(2):280-5. PubMed ID: 234263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fatty acids on human serum albumin binding centers.
    Dobretsov GE; Syrejshchikova TI; Smolina NV; Uzbekov MG
    Bull Exp Biol Med; 2012 Jul; 153(3):323-6. PubMed ID: 22866302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fluorescent reporter detects details of aromatic ligand interference in drug-binding sites of human serum albumin.
    Dobretsov G; Smolina N; Syrejshchikova T; Brilliantova V; Uzbekov M
    Biochem Biophys Res Commun; 2016 Sep; 478(1):462-466. PubMed ID: 27318089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a human serum albumin structure-based fluorescent probe for bioimaging in living cells.
    Wang Q; Fan J; Zhou Y; Xu S
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Mar; 269():120769. PubMed ID: 34942415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A selective and sensitive fluorescent albumin probe for the determination of urinary albumin.
    Wu YY; Yu WT; Hou TC; Liu TK; Huang CL; Chen IC; Tan KT
    Chem Commun (Camb); 2014 Oct; 50(78):11507-10. PubMed ID: 25133275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding sites of fluorescent probes on human serum albumin.
    Muller N; Lapicque F; Drelon E; Netter P
    J Pharm Pharmacol; 1994 Apr; 46(4):300-4. PubMed ID: 7519671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel lophine-based fluorescence probe and its binding to human serum albumin.
    Kishikawa N; Ohyama K; Saiki A; Matsuo A; Ali MF; Wada M; Nakashima K; Kuroda N
    Anal Chim Acta; 2013 May; 780():1-6. PubMed ID: 23680544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fluorescent method of determining mass concentration of human serum albumin].
    Gryzunov IuA; Miller IuI; Dobretsov GE; Pestova AB
    Klin Lab Diagn; 1994; (5):27-31. PubMed ID: 7850232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anion-binding centers of human serum albumin during an N-F conformation transition and in isolated albumin and blood serum].
    Miller IuI; Dobretsov GE; Kolchin IuA
    Biofizika; 1991; 36(3):505-8. PubMed ID: 1911922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of acrylodan with human serum albumin. A fluorescence spectroscopic study.
    Moreno F; Cortijo M; González-Jiménez J
    Photochem Photobiol; 1999 Nov; 70(5):695-700. PubMed ID: 10568165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
    Davilas A; Koupparis M; Macheras P; Valsami G
    J Pharm Pharmacol; 2006 Nov; 58(11):1467-74. PubMed ID: 17132209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the affinity of drugs toward serum albumin by measurement of the quenching of the intrinsic tryptophan fluorescence of the protein.
    Epps DE; Raub TJ; Caiolfa V; Chiari A; Zamai M
    J Pharm Pharmacol; 1999 Jan; 51(1):41-8. PubMed ID: 10197416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interaction of N-phenyl-1-amino-8-sulfonaphthalene (ANS) with albumin in blood in hyperbilirubinemia].
    Dobretsov GE; Miller IuI; Kolchin IuA
    Ukr Biokhim Zh (1978); 1990; 62(5):29-33. PubMed ID: 2270620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Features of the binding of the fluorescent probe K-35 to albumin].
    Dobretsov GE; Syreĭshchikova TI; Gryzunov IuA; Smolina NV; Komar AA
    Biofizika; 2010; 55(2):213-9. PubMed ID: 20429273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spectrofluorometric detection of protein with a novel hydrophilic cyanine dye].
    Lin XC; Guo LQ; Lin YX; Xie ZH
    Guang Pu Xue Yu Guang Pu Fen Xi; 2007 Sep; 27(9):1775-9. PubMed ID: 18051527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [K-35, a fluorescent probe for albumin study: optical properties].
    Dobretsov GE; Gryzunov IuA; Syreĭshchikova TI; Smolina NV; Svetlichnyĭ VIu; Poliak BM
    Biofizika; 2012; 57(3):405-9. PubMed ID: 22873062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible binding of antidiabetic drugs, repaglinide and gliclazide, with human serum albumin.
    Seedher N; Kanojia M
    Chem Biol Drug Des; 2008 Oct; 72(4):290-6. PubMed ID: 18844675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.